Walgreens Boots Alliance Accelerates Full Acquisition of High-Performing Shields Health Solutions

Published on September 20, 2022

DEERFIELD, Ill.–(BUSINESS WIRE)– Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the acceleration of its plans for full ownership of Shields Health Solutions (Shields), which is delivering strong financial performance, clinical excellence and value-add contributions to WBA’s business. WBA has entered into a definitive agreement to acquire the remaining 30% stake (approximately 35% on a […]

Continue reading on website
Other news

InnovAge Announces Financial Results for the Fiscal Year and Fourth Quarter Ended June 30, 2022

September 13, 2022
DENVER, Sept. 13, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced financial results for its fiscal fourth quarter and full year ended June 30, 2022.

Cellistic And Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction

September 20, 2022
GOSSELIES and MONT-SAINT-GUIBERT, BELGIUM (September 20, 2022) – Cellistic, the cell therapy development and manufacturing business of Ncardia holding SA, and Celyad Oncology (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, announced today a transaction whereby Cellistic will